scholarly journals Assay of active pharmaceutical ingredients in drug products based on relative response factors: Instrumentation insights and practical considerations

2021 ◽  
Vol 194 ◽  
pp. 113760
Author(s):  
Lisa (Song) Liu ◽  
Ariel Mouallem ◽  
Kang Ping Xiao ◽  
Jerry Meisel
2021 ◽  
Author(s):  
Do Hee Lee ◽  
Seongchul Park ◽  
Su Hyeon Hwang ◽  
Jeongmi Lee ◽  
Han Bin Oh ◽  
...  

A solvent-free headspace gas chromatography – mass spectrometry (SF-HS-GC/MS) method was developed and validated for screening of N-nitrosodimethylamine (NDMA) in various active pharmaceutical ingredients (APIs) and drug products. Experimental parameters...


2007 ◽  
Vol 59 (1) ◽  
pp. 29-37 ◽  
Author(s):  
K ALSANTE ◽  
A ANDO ◽  
R BROWN ◽  
J ENSING ◽  
T HATAJIK ◽  
...  

2018 ◽  
Vol 24 (21) ◽  
pp. 2456-2472 ◽  
Author(s):  
Chandrakant R. Malwade ◽  
Haiyan Qu

Background: Pharmaceutical industry is witnessing increased pressure to introduce innovative and efficient processes for manufacturing Active Pharmaceutical Ingredients (APIs) in order to be competitive as well as to meet the stringent product quality requirements set by regulatory authorities. Crystallization with its ability to engineer the final product to the desired qualities such as purity, polymorphic form, particle size and shape is one of the most important steps involved in the manufacturing of APIs. Therefore, development of crystallization processes with better understanding of process parameters and their impact on quality of APIs and subsequently the drug products assume great significance for the pharmaceutical industry. Methods: This review paper focuses on the application of PAT tools, an integral part of Quality by Design (QbD) approach, for better understanding, control, and design of crystallization processes in the manufacturing of APIs. Results: Firstly, various steps involved in the drug development process are introduced briefly with emphasis on crystallization as one of the most important steps in manufacturing of drug products. Secondly, Critical Quality Attributes (CQAs) of drug products, their dependence on material attributes of APIs and role of crystallization in manipulating material attributes of APIs has been discussed. Finally, application of PAT tools such as advanced process analyzers for continuous monitoring, chemometric methods for multivariate data analysis, and control strategy for APIs crystallization processes has been reviewed along with some examples. Conclusion: Application of PAT in crystallization of APIs facilitates development of robust processes that works within the design space to produce the drug products of consistent quality. Furthermore, it opens up the opportunities for continuous improvement of the process by generating knowledge base of existing processes.


Author(s):  
Наум Аронович Эпштейн

Представлены формулы для расчета коэффициентов относительной чувствительности RRF (relative response factors) и поправочных коэффициентов F (correction factors) примесей, а также формулы, необходимые для понимания сущности коэффициентов RRF и F. Рассмотрены основные способы определения поправочных коэффициентов и их ограничения (условия, выполнение которых необходимо для корректного определения RRF и F). Эти ограничения не отражены в Европейской фармакопее и в Фармакопее США, но от их учета зависит правильность определения значений поправочных коэффициентов. Приведены примеры и даны рекомендации для надежного определения и правильного использования поправочных коэффициентов.


2019 ◽  
Vol 69 (12) ◽  
pp. 3590-3592
Author(s):  
Nela Bibire ◽  
Romeo Iulian Olariu ◽  
Luminita Agoroaei ◽  
Madalina Vieriu ◽  
Alina Diana Panainte ◽  
...  

Active pharmaceutical ingredients such as isoniazid, pyrazinamide and rifampicin are among the most important first-line anti-tuberculosis drugs. A simple, rapid and sensitive reversed phase-high performance liquid chromatographic assay method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin has been developed. Separation of the interest compounds was achieved in a 10 min chromatographic run in gradient elution mode on a Zorbax SB-C18 stainless steel column (150 � 4 mm, 5 mm) using a guard column containing the same stationary phase. The gradient elution was carried out with a mobile phase of 10% CH3CN aqueous solution for channel A and 50% CH3CN in pH = 6.8 phosphate buffer (20 mM), to which 1.5 mL triethylamine were added for channel B. Quantification of the analyzed substances was carried out spectrophotometrically at 269 nm. Detection limits of 0.48 mg/L for isoniazid, 0.52 mg/L for pyrazinamide and 0.48 mg/L for rifampicin were established for the developed assay method. The present work showed that the proposed analysis method was advantageous for simple and rapid analysis of the active pharmaceutical ingredients in pharmaceuticals and biological fluids.


Sign in / Sign up

Export Citation Format

Share Document